Aptevo Therapeutics Inc. (APVO) vs Lexaria Bioscience Corp. (LEXX)
A side-by-side comparison of Aptevo Therapeutics Inc. and Lexaria Bioscience Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.83HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
LEXX
Lexaria Bioscience Corp.
$2.86HealthcareDelayed quote: Oct 6, 2026, 10:37 AM EDT
Total return — APVO vs LEXX
growth of $100 · dividends reinvested · last 6yAPVO -100.0% (-93.2%/yr)LEXX -95.9% (-41.2%/yr)LEXX compounded faster over this window
Log scale — wide-divergence pair
APVO LEXX
APVO vs LEXX: by the numbers
- •LEXX is the larger company ($5M vs $4M market cap).
- •Both run net losses; APVO's is the smaller (0.00% vs -3985.58% net margin).
Metrics side by side
Valuation
| Metric | APVO | LEXX |
|---|---|---|
| P/S ratio | N/A | 24.36 |
| P/B ratio | 0.66 | 1.00 |
Profitability
| Metric | APVO | LEXX |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -1683.01% |
| Net margin | 0.00% | -3985.58% |
| ROE | -437.15% | -163.18% |
| ROIC | -288.14% | -175.26% |
Growth (annualized)
| Metric | APVO | LEXX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.92% |
| Total return CAGR (5Y) | -95.30% | -50.86% |
Frequently asked
- How have APVO and LEXX total returns compared?
- Over the past 5 years, APVO delivered -95.30% and LEXX delivered -50.86% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.